Axsome Therapeutics paid its 5 named executives $24.6M in total in FY2025 (Dec). CEO Herriot Tabuteau, M.D. was paid $10.3M of that.
Pay$100 in the stock at the end of FY20 → $224
Pay of each named executive
Herriot Tabuteau, M.D.Chief Executive Officer, President and Chairman of the Board
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Mark Jacobson, M.A.Chief Operating Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Nick Pizzie, C.P.A., M.B.A.Chief Financial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Hunter Murdock, Esq.General Counsel
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | |||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Ari Maizel, M.B.A.Chief Commercial Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed |
3 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 4 peers with pay on file was $12.9M. CEO pay of Axsome Therapeutics for that year is not on file.
- 1BridgeBio Pharma
- 2INSMED
- 3Ultragenyx Pharmaceutical
- 4Zai Lab
- 5Axsome TherapeuticsThis companyNot disclosed
- 6ACADIA Pharmaceuticals, Inc.Not disclosed
- 7Amicus Therapeutics, Inc.Not disclosed
- 8Apellis Pharmaceuticals, Inc.Not disclosed
- 9Catalyst Pharmaceuticals, Inc.Not disclosed
- 10Collegium Pharmaceutical, Inc.Not disclosed
- 11Corcept TherapeuticsNot disclosed
- 12Denali Therapeutics Inc.Not disclosed
- 13Harmony Biosciences Holdings, Inc.Not disclosed
- 14Intra Cellular Therapies, Inc.Not disclosed
- 15Sage Therapeutics, Inc.Not disclosed
- 16Supernus Pharmaceuticals, Inc.Not disclosed
- 17Vanda Pharmaceuticals Inc.Not disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.